Analyst Price Targets — DRTS
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| June 4, 2026 9:05 am | — | Barclays | $17.00 | $10.58 | TheFly | Alpha Tau price target raised to $17 from $15 at Barclays |
| May 28, 2026 7:36 am | Lukas Shumway | Barclays | $15.00 | $10.29 | StreetInsider | Barclays Starts Alpha Tau Medical Ltd. (DRTS) at Overweight |
| May 19, 2026 11:01 am | — | Piper Sandler | $8.00 | $10.03 | TheFly | Alpha Tau price target raised to $8 from $5 at Piper Sandler |
| May 12, 2026 10:15 am | — | H.C. Wainwright | $15.00 | $10.34 | TheFly | Alpha Tau price target raised to $15 from $12 at H.C. Wainwright |
| February 24, 2026 3:29 pm | Yi Chen | H.C. Wainwright | $12.00 | $7.50 | TheFly | Alpha Tau price target raised to $12 from $9 at H.C. Wainwright |
| September 3, 2025 10:51 am | Yi Chen | H.C. Wainwright | $9.00 | $3.59 | StreetInsider | H.C. Wainwright Reiterates Buy Rating on Alpha Tau Medical Ltd. (DRTS) |
| May 21, 2024 8:51 am | Jason Bednar | Piper Sandler | $7.00 | $2.91 | StreetInsider | Piper Sandler Reiterates Overweight Rating on Alpha Tau Medical Ltd. (DRTS) |
| November 23, 2022 6:21 am | — | Piper Sandler | $12.00 | $3.75 | Benzinga | Piper Sandler Maintains Overweight on Alpha Tau Medical, Lowers Price Target to $12 |
Latest News for DRTS
Alpha Tau Successfully Treats First Immunocompromised Patient with Recurrent Cutaneous Squamous Cell Carcinoma in its ADMIRE Study at Banner MD Anderson
AMPX, DRTS and BELFB have been added to the Zacks Rank #5 (Strong Sell) List on July 7, 2026.
DRTS, CANG and LAZ have been added to the Zacks Rank #5 (Strong Sell) List on July 2, 2026.
Oramed Releases Letter to Shareholders, Highlighting Russell 2000/3000 Index Inclusion, Scilex Loan Repayment, Strategic Portfolio Appreciation
Alpha Tau Successfully Treats First Recurrent Glioblastoma Patient Outside of the United States with Alpha DaRT® at Hadassah Medical Center in Israel
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for DRTS.
U.S. House Trading
No House trades found for DRTS.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.